Overview

Study of Axitinib in Patients With Recurred or Metastatic Adenoid Cystic Carcinoma

Status:
Unknown status
Trial end date:
2020-08-01
Target enrollment:
Participant gender:
Summary
To understand efficacy of axitinib in recurred or metastatic adenoid cystic carcinoma
Phase:
Phase 2
Details
Lead Sponsor:
Seoul National University Hospital
Treatments:
Axitinib